It's been a rocky road and rollercoaster for the last 5 years or so but definitely worth a punt even at the increased price as the directors have share options which are not worth much as yet so the incentive is there ! Plus they have only just hit profit so only the most nervous or cash hungry investors will have cashed in up to this point, even with the new issue which at least is at market price !!!
Bull points 1/. Check out the CEO and Chairman's history. Their roots are top jobs at Multi billion pound agrochems. They chose to join PIm , a £25million minnow. Brubaker has done everything he set out to do 3 years ago. Someone to have faith in 2/. Last two placings have been at prevailing SP, no discount, great signpost. 3/. The relationship with Bayer is transformational. No more door knocking but proper roots to market with a top class partner 4/. look at the latest article on proactive investors which references new products for soya and new products for wheat. don't expect new product launch for at least 2 years but from then on we could see new products every year or two as results from r&d investment come through. Broad acre products are the key as the applicable market is massive. veritas is a real winner product
bear points 1/. Personally, I do not expect Ametros to do brilliantly this season. The apple market has collapsed with over supply caused by trade sanctions between Russia and Europe. I can't see farmers dropping money on a product which, atm, is barely worth harvesting. Time will tell here, atm, they say they are trading in line.. 2/. you never know when another company will come up with a wizz bang product…it is not something I worry about unduly , not something I can really monitor 3/. i imagine a lot of retail investors will have sold out/taken profit over the past 6 months. i have sold down half of my holding( been here for over 6 years) but will hold the rest now and watch the story unfold.
All, PIM has just come onto my radar for the first time. It seems like a fantastic company with great growth potential. I am particurlarly interested in there Bayer deal. I have three questions which I had hoped you could help with: 1)The share price has performed very well in the last few months-12mths. Have I missed this opportunity or do you see the share pruce continuing to perform well? (I am aware that peel hunt seems to think the company could be valued at £1, with a forecast PE (at todays share price) in 2017 of 8 -which if comes true would represent mega-upside) 2)The recent product launh in Brazil has been a great success particurlarly with Bayer involved. Does the company have any other products in the pipeline? When could we expect these to come to fruition? 3)What are the major risks to PIM? I guess competition would be one but I expect that the involvement with Bayer would reduce this risk somewhat.
Would really appreciate any insight people could give.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.